Pulmonary function changes after nebulised and intravenous frusemide in ventilated premature infants

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 77, Issue 1, 1997, Pages

  Prabhu, Vishwanath G ^a   Keszler, Martin ^a   Dhanireddy, Ramasubbareddy ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Chronic lung disease of prematurity; Inhaled frusemide; Pulmonary mechanics

Indexed keywords

CHLORIDE; FUROSEMIDE; POTASSIUM; SODIUM;

AIRWAY RESISTANCE; ARTICLE; ARTIFICIAL VENTILATION; CHLORIDE URINE LEVEL; CHRONIC LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; HUMAN; INFANT; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG COMPLIANCE; LUNG FUNCTION; MALE; MEDICAL NEBULIZER; NEWBORN; POTASSIUM URINE LEVEL; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SODIUM URINE LEVEL; TIDAL VOLUME; URINE VOLUME;

EID: 0031418939     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/fn.77.1.F32     Document Type: Article

References (24)

1. Brown ER, Stark A, Sosenko I, Lawson EL, Avery ME. Bronchopulmonary dysplasia- possible relationship to pulmonary edema. J Pediatr 1978; 92:982-4.
2. Spitzer AR, Fox WW, Delivoria-Papadopoulous M. Maximum diuresis- a factor in predicting recovery from respiratory distress syndrome and development of bronchopulmonary dysplasia. J Pediatr 1981; 98:476-9.
3. Blanchard PW, Brown TM, Coates AL. Pharmacotherapy in bronchopulmonary dysplasia. Clin Perinatol 1987; 14:881-910.
4. Patel H, Yeh TF, Jain R, Pildes R. Pulmonary and renal responses to furosemide in infants with stage 3-4 BPD. Am J Dis Child 1985;139:917-9.
5. Kao L, Warburton D, Cheng M, Cedeno C, Platzker A, Keens T. Effect of oral diuretics on pulmonary mechanics in infants with chronic BPD: results of double blind cross over sequential trial. Pediatrics 1984;74:37-44.
6. McCann EM, Deming DD, Brady JP. Lasix improves lung function in infants with chronic lung disease. Clin Res 1983;31:141A.
7. Najak KZ, Harris EM, Lazzara A, Pruitt AW. Pulmonary effects of furosemide in premature infants with lung disease. Pediatr Res 1981;15:783-7.
8. Anonymous. Inhaled furosemide and asthma [editorial]. Lancet 1990;21:944-6.
9. Bianco S, Pieroni MG, Refini RM, Robuschi M, Vaghi A, Sestini P. Inhaled loop diuretics as potential new anti-asthmatic drugs. Eur Respir J 1993;6:130-4.
10. Rastogi A, Luayon M, Ajayi OA, Pildes RS. Nebulized furosemide in infants with bronchopulmonary dysplasia. J Pediatr 1994;125:976-9.
11. Bhutani VK, Siviri EM, Abbasi S, Shaffer TH. Evaluation of neonatal pulmonary mechanics and energies; A two factor least mean square analysis. Pediatr Pulmonol 1988;4:150-8.
12. Beeram M, Dhanireddy R. Urinalysis: Direct versus diaper collection. Clin Pediatr 1991;30:278-280.
13. Bland RD. Edema formation in the newborn lung. Clin Perinatol 1982;9:593-611.
14. Rush MG and Hazinski TA. Current therapy of bronchopulmonary dysplasia. Clin Perinatol 1992;19:563-90.
15. Rush MG, Engelhardt B and Parker RA. Double blind, placebo-controlled trial of alternate day furosemide therapy in infants with chronic bronchopulmonary dysplasia. J Pediatr 1990;117:112-18.
16. Ali J, Chernicki W and Wood LD. Effect of furosemide in canine low pressure pulmonary edema. J Clin Invest 1979;64:1494-504.
17. Nichol GM, Alton EW, Nix A, Geddes DM, Chung KF, Barnes PJ. Effect of inhaled furosemide on metabisulfite-and methacholine-induced bronchoconstriction and nasal potential difference in asthmatic subjects. Am Rev Respir Dis 1990;142:576-80.
18. O'Connor BJ, Chung KF, Chen-Worsdell YM, Fuller RW, Barnes PJ. Effect of inhaled furosemide and bumetanide on adenosine 5′-monophosphate- and sodium metabisulfite-induced bronchoconstriction in asthmatic subjects. Am Rev Respir Dis 1991;143:1329-33.
19. O'Donnell WJ, Rosenberg M, Niven RW, Drazen JM, Israel E. Acetazolamide and furosemide attenuate asthma induced by hyperventilation of cold, dry air. Am Rev Respir Dis 1992;146:1518-23.
20. Foresi A, Pelucchi A, Mastropasqua B, Cavigioli G, Carlesi RM, Marazzini L. Effect of inhaled furosemide and torasemide on bronchial response to ultrasonically nebulized distilled water in asthmatic subjects. Am Rev Respir Dis 1992;146:364-8.
21. Polosa R, Lau LCK, Holgate ST. Inhibition of adenosine 5′-monophosphate and methacholine induced bronchoconstriction in asthma by inhaled furosemide. Eur Respir J 1990;3:665-72.
22. Pavord ID, Wisniewski A, Tattersfield AE. Inhaled frusemide and exercise induced asthma: evidence of a role for inhibitory prostanoids. Thorax 1992;47:797-800.
23. Anderson SD, Temple DM, Wei HE. Inhibition of furosemide of inflammatory mediators from lung fragments (letter). N Engl J Med 1991;324:131.
24. Mosacato G, Dellabianca A, Falagiani P, Mistrello G, Rampulla C. Inhaled furosemide prevents both the bronchoconstriction and the increase in neutrophil chemotactic activity induced by ultrasonic 'fog' of distilled water in asthmatics. Am Rev Respir Dis 1991;143:561-6.